• Employees
  • About us
    • Mandate and owners
    • Strategy and goals
    • Our funding
    • Our competence
    • Board of Directors
    • Summary of the year
  • News
  • Norwegian Bokmål
Inven2 logo hvit
  • Innovation
    • About innovation
    • Information to researchers
    • Information to investors
    • Information to industry
    • Ideprisen
  • Clinical studies
    • About clinical trials
    • Information to industry
    • Information to study personnel
  • Licensing opportunities
Inven2 logo
  • Employees
  • About us
    • Mandate and owners
    • Strategy and goals
    • Our funding
    • Our competence
    • Board of Directors
    • Summary of the year
  • News
  • Innovation
    • About innovation
    • Information to researchers
    • Information to industry
    • Information to investors
    • Ideprisen
  • Clinical studies
    • About clinical trials
    • Information to industry
    • Information to study personnel
  • Licensing opportunities
  • Norwegian Bokmål
A unique biological super-taxi has been developed

A unique biological super-taxi has been developed

by Elisabeth Kirkeng Andersen | Oct 15, 2020

Most protein-based therapeutics must be injected to be effective. That is both stressful for the patient and costly for the healthcare system. Researchers at the University of Oslo and Oslo University Hospital have recently published an article in the highly reputed...

Recent Posts

  • Will revolutionise CAR-T therapy with a Norwegian licence
  • Vital licences
  • A unique biological super-taxi has been developed
  • Clinical studies – important for Norwegian companies
  • First in the world with unique immunotherapy

Archives

  • January 2022
  • November 2021
  • October 2020
  • September 2020
  • August 2020

Inven2 AS

Address

Gaustadalléen 21

0349 Oslo

VAT no: 995 495 899 nr: 995 495 899

Mailing address

P.O. Box 1061 Blindern

0316 Oslo

Contact us

Employees

post@inven2.com

Practical

About Inven2

Cookies

  • Follow
  • Follow
  • Follow
UiO Logo
Færd kommunikasjon